Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050166

Options or other derivatives

  • EVP, Strategy & Innovation acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBIN SHERRINGTON EVP, Strategy & Innovation 2019-09-16 Grant or award · Stock Option (Right to Buy) +45,000 45,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…